ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 34 filers reported holding ATYR PHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $10,000 | – | 27,029 | +2702800.0% | 0.00% | – |
| Q1 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q4 2017 | $13,000 | -59.4% | 3,648 | -42.3% | 0.00% | – |
| Q3 2017 | $32,000 | – | 6,323 | +6555.8% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 95 | -94.0% | 0.00% | – |
| Q4 2016 | $3,000 | -95.4% | 1,576 | -92.3% | 0.00% | – |
| Q3 2016 | $65,000 | -12.2% | 20,445 | -22.5% | 0.00% | – |
| Q2 2016 | $74,000 | -2.6% | 26,366 | +37.1% | 0.00% | – |
| Q1 2016 | $76,000 | -64.8% | 19,230 | -12.7% | 0.00% | – |
| Q4 2015 | $216,000 | +32.5% | 22,032 | +38.6% | 0.00% | – |
| Q3 2015 | $163,000 | -18.1% | 15,900 | +47.9% | 0.00% | – |
| Q2 2015 | $199,000 | – | 10,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $3,930,000 | 4.66% |
| EcoR1 Capital, LLC | 976,986 | $2,101,000 | 0.67% |
| TANG CAPITAL MANAGEMENT LLC | 279,425 | $601,000 | 0.32% |
| Rock Springs Capital Management LP | 475,000 | $1,021,000 | 0.07% |
| Quotient Investors, LLC | 22,200 | $48,000 | 0.03% |
| Alyeska Investment Group, L.P. | 1,072,108 | $2,305,000 | 0.02% |
| TIVERTON ASSET MANAGEMENT LLC | 95,318 | $205,000 | 0.01% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $171,000 | 0.01% |
| Acrospire Investment Management LLC | 12,683 | $27,000 | 0.01% |
| Glen Harbor Capital Management LLC | 179,724 | $386,000 | 0.01% |